Table 2 Description of phenotypic, commercially available methods of antimicrobial susceptibility testing

From: Next-generation rapid phenotypic antimicrobial susceptibility testing

Technology principles

Detailed technology description

Commercial name

Company or organization

Advantagesa

Limitationsa

Macroscopic growth measured visually

Direct visualization of bacterial growth on solid media following exposure to antimicrobial gradient strips

ETEST®81

bioMérieux SA

No instruments required

Low barrier to implementation

Pure culture required

Skilled interpretation required

Direct visualization of bacterial growth on solid media following exposure to antimicrobial gradient strips

MTS™ (MIC Test Strip)82

Liofilchem S.r.l.

No instruments required

Low barrier to implementation

Pure culture required

Skilled interpretation required

Direct visualization of bacterial growth on solid media after exposure to antimicrobial discs; plates inoculated directly from positive blood cultures

Rapid AST directly from positive blood cultures27

EUCAST

No instruments required

Direct from positive blood culture

Not suited to laboratories with fixed daily workflow

Results are preliminary only – final AST results using conventional methods required

Currently validated for 8 species only

Bacterial concentration detected via light absorbance

Directly read or automated broth microdilution available in pre-formatted cassettes

ComASP®83

Liofilchem S.r.l.

No instruments required

Pure culture required

Automated broth microdilution

VITEK® 284

bioMérieux SA

Automated; part of extensive instrument ecosystem

Pure culture required

Manual dilution steps required

Automated broth microdilution using metabolic indicator dye and light absorbance measurements

BD Phoenix™85

Becton Dickinson and Company

Automated; part of extensive instrument ecosystem

Pure culture required

Manual dilution steps required

Visualization of bacterial concentration during exposure to antimicrobials using light absorbance measurements; presence of indicator dye not specified

ASTar®28

Q-linea AB

Does not require manual dilution steps

Pure culture required

Bacterial concentration detected via fluorescence production

Automated broth microdilution using fluorescence detection and universal fluorescent dye

Sensititre™86

Thermo Fisher Scientific, Inc.

No instruments required

Customizable choice of antimicrobials

Pure culture required

Manual dilution steps required

Visualization of bacterial concentration during exposure to antimicrobials using fluorescence detection and universal fluorescent dye

DxM MicroScan WalkAway ID/AST System87

Beckman Coulter, Inc.

Automated; part of extensive instrument ecosystem

Pure culture required

Manual dilution steps required

Visualization of proportion of viable bacteria during exposure to antimicrobials using flow cytometry and universal fluorescent dyes with single-cell resolution

FASTinov AST29

FASTinov S.A.

Direct from positive blood culture

Rapid TAT of 2 h from positive blood cultures

Flow cytometry instrument required

Requires separate workflow for species ID

Bacterial concentration detected via advanced imaging or laser-based methods

Visualization of bacterial concentration during exposure to antimicrobials using laser light scattering

Alfred 60/AST30

Alifax S.r.l.

Integrated liquid culture and AST system that begins AST as soon as culture ready

Requires separate workflow for species ID

Visualization of bacterial replication during exposure to antimicrobials using microcolony-resolution light microscopy

dRAST™31

QuantaMatrix Inc.

Direct from positive blood culture

Rapid TAT of 4 h from positive blood cultures

Runs 12 samples simultaneously

Requires separate workflow for species ID

Visualization of individual bacterial replication during exposure to antimicrobials using phase contrast microscopy within nanofluidic channels

PA-100 AST System88

SYSMEX Europe SE

Direct from urine specimen

Rapid TAT of 45 min from sample insertion

No sample preparation; designed for point-of-care use

Does not provide species ID

Does not work with samples containing more than one organism

Urine specimens only

One sample per run

Visualization of bacterial replication during exposure to antimicrobial gradients within a microfluidic device using single-cell resolution dark field microscopy

QuickMIC®32

Gradientech AB

Direct from positive blood culture

Rapid TAT of 4 h from positive blood cultures

Modular

Only has gram-negative AST panel available

Requires separate workflow for species ID

Bacterial concentration detected via physical interactions

Detection of individual bacterial mass during exposure to antimicrobials using a cantilever within microfluidic channel

LifeScale33

Affinity Biosensors

Direct from positive blood culture

Rapid TAT of 4.5 h from positive blood cultures

Runs 4 patient samples simultaneously

Only has gram-negative AST panel available

Requires separate workflow for species ID

Bacterial growth measured indirectly via metabolic activity

Detection of bacterial metabolic changes during exposure to antimicrobials using microcantilever movements after bacterial attachment to cantilever

Resistell™34

Resistell AG

Direct from positive blood culture

Rapid TAT of 2 h from positive blood cultures

Runs 12 samples simultaneously

Requires separate workflow for species ID

Detection of gaseous bacterial metabolic products during exposure to antimicrobials using colour-changing sensors monitored via camera

VITEK® REVEAL™35

bioMérieux SA

Direct from positive blood culture

Rapid TAT of 6 h from positive blood cultures

Modular

Requires separate workflow for species ID

Bacterial concentration and/or activity measured via multiple methods

Visualization of bacterial replication during exposure to antimicrobials using both fluorescence and dark field microscopy with universal rRNA probes; image processing via morphokinetic cellular analysis (incorporates multiple imaging features of growth at single-cell resolution); performs automated removal of sample matrix via gel electrophoresis prior to assay

Accelerate Pheno®36

Accelerate Diagnostics, Inc.

Integrated species ID

Direct from positive blood culture

Rapid TAT of 7 h from positive blood cultures

Modular

 

Visualization of bacterial surface area during exposure to antimicrobials using both fluorescence microscopy and charge-based fluorescent dye with specific binding to bacterial surface as well as visualization of metabolic activity using a metabolic indicator dye and light absorbance measurements

Selux Next Generation Phenotyping System89

Selux Diagnostics, Inc.

Automated

Direct from positive blood culture

Rapid TAT of 7 h from positive blood cultures

Requires separate workflow for species ID

  1. Commercial names in bold denote methods in wide use90,91.aKey advantages and limitations of commercial technologies are outlined, with a focus on implementation considerations, user experience, and clinical use cases. While important, we did not include economic considerations as these are beyond the scope of our review and are highly context-dependent. Several technologies require complex instruments and workflows; they also frequently require an ecosystem of supporting technologies for AST-related functions such as species identification without which MIC data is not interpretable. Technologies with a low barrier to implementation and/or integrated species identification are indicated in the Advantages column.